Eltrombopag for Treatment of Thrombocytopenia After Autologous Stem Cell Transplantation in Children: Single Center Experience
Our study indicates the efficacy and safety of ELT for treating PIT and SFPR after autologous HSCT in pediatric patients. However, more studies are needed to confirm these findings in children.
Authors
- Yöntem Yaman (ORCID: https://orcid.org/0000-0002-9710-8653)
- Kürşat Özdilli (ORCID: https://orcid.org/0000-0002-7129-5024)
- Serdar Nepesov (ORCID: https://orcid.org/0000-0002-4551-5433)
- Nihan Bayram (ORCID: https://orcid.org/0000-0002-9688-5223)
- Murat Elli (ORCID: https://orcid.org/0000-0002-0476-5452)
- Işık Odaman Al (ORCID: https://orcid.org/0000-0003-4292-1409)
- Sema Anak (ORCID: https://orcid.org/0000-0001-8489-7449)
Institutions
- Istanbul Medipol University (TR)
- Palmetto Hematology Oncology (US)
Publication Details
- Journal
- Journal of Pediatric Hematology/Oncology
- Published
- 2024-11-11
- DOI
- https://doi.org/10.1097/mph.0000000000002971
- Citations
- 3
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.36